# A Human Proof of Concept Study for [11C]-RO5011232 as Radiotracer and Study of the Binding of RO4917523 to Human mGlu5 Brain Receptor at Steady-State in Healthy Volunteers

> **NCT01483469** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 56 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** RO4917523
- **DRUG:** RO5011232

## Key facts

- **NCT ID:** NCT01483469
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01483469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01483469, "A Human Proof of Concept Study for [11C]-RO5011232 as Radiotracer and Study of the Binding of RO4917523 to Human mGlu5 Brain Receptor at Steady-State in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01483469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*